Pharmacokinetics of mycophenolic acid and estimation of exposure using multiple linear regression equations in Chinese renal allograft recipients
- PMID: 17465638
- DOI: 10.2165/00003088-200746050-00002
Pharmacokinetics of mycophenolic acid and estimation of exposure using multiple linear regression equations in Chinese renal allograft recipients
Abstract
Objectives: To investigate the pharmacokinetics of mycophenolic acid (MPA) in Chinese adult renal allograft recipients, and to generate the validated model equations for estimation of the MPA area under the plasma concentration-time curve from 0 to 12 hours (AUC(12)) with a limited sampling strategy.
Patients and methods: The pharmacokinetics in 75 Chinese renal allograft recipients treated with mycophenolate mofetil 2 g/day in combination with cyclosporin and corticosteroids were determined. The MPA concentration was assayed by high-performance liquid chromatography at pre-dose (C(0)) and at 0.5 (C(0.5)), 1 (C(1)), 1.5 (C(1.5)), 2 (C(2)), 4 (C(4)), 6 (C(6)), 8 (C(8)), 10 (C(10)) and 12 (C(12)) hours after dosing on day 14 post-transplant. Patients were randomly divided into: (i) a model group (n = 50) to generate the model equations by multiple stepwise regression analysis for estimation of the MPA AUC by a limited sampling strategy; and (ii) a validation group (n = 25) to evaluate the predictive performance of the model equations.
Results: The mean MPA AUC(12) was 52.97 +/- 15.09 mg . h/L, ranging from 24.0 to 102.3 mg . h/L. The patient's age and serum albumin level had a significant impact on the MPA AUC(12). The correlation between the pre-dose MPA trough level (C(0)) and the MPA AUC(12) was poor (r(2) = 0.02, p = 0.33). Model equations 7 (MPA AUC(12) = 14.81 + 0.80 . C(0.5) + 1.56 . C(2) + 4.80 . C(4), r(2) = 0.70) and 11 (MPA AUC(12) = 11.29 + 0.51 . C(0.5) + 2.13 . C(2) + 8.15 . C(8), r(2) = 0.88) were selected for MPA AUC calculation in Chinese patients, resulting in good agreements between the estimated MPA AUC and the full MPA AUC(12), with a mean prediction error of +/-10.1 and +/-6.9 mg . h/L, respectively.
Conclusion: In Chinese renal allograft recipients, MPA pharmacokinetics manifest substantial interindividual variability, and the MPA AUC(12) tends to be higher than that in Caucasian patients receiving the same dose of mycophenolate mofetil. Two validated model equations with three sampling timepoints are recommended for MPA AUC estimation in Chinese patients.
Similar articles
-
Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19817503
-
Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.Clin Pharmacokinet. 2007;46(2):175-85. doi: 10.2165/00003088-200746020-00005. Clin Pharmacokinet. 2007. PMID: 17253887 Clinical Trial.
-
A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.Clin Ther. 2006 Jun;28(6):893-905. doi: 10.1016/j.clinthera.2006.06.015. Clin Ther. 2006. PMID: 16860172
-
Clinical pharmacokinetics of mycophenolate mofetil.Clin Pharmacokinet. 1998 Jun;34(6):429-55. doi: 10.2165/00003088-199834060-00002. Clin Pharmacokinet. 1998. PMID: 9646007 Review.
-
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.Transplant Rev (Orlando). 2011 Apr;25(2):47-57. doi: 10.1016/j.trre.2010.06.001. Epub 2010 Dec 28. Transplant Rev (Orlando). 2011. PMID: 21190834
Cited by
-
Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms.Pharmgenomics Pers Med. 2014 Dec 5;7:379-85. doi: 10.2147/PGPM.S72760. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25540593 Free PMC article.
-
Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients.Front Pharmacol. 2021 Apr 12;12:652333. doi: 10.3389/fphar.2021.652333. eCollection 2021. Front Pharmacol. 2021. PMID: 33912061 Free PMC article.
-
Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients.Front Pharmacol. 2020 Mar 20;11:340. doi: 10.3389/fphar.2020.00340. eCollection 2020. Front Pharmacol. 2020. PMID: 32265712 Free PMC article.
-
The Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome.Molecules. 2021 Jun 18;26(12):3723. doi: 10.3390/molecules26123723. Molecules. 2021. PMID: 34207320 Free PMC article.
-
A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration-Time Curve Estimation.Eur J Drug Metab Pharmacokinet. 2021 Nov;46(6):721-742. doi: 10.1007/s13318-021-00713-0. Epub 2021 Sep 4. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34480746 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous